Voices of Bio: Strategic Partnerships 

Sponsored by: Saul Ewing and Venable LLP
Date: June 23, 2009
Time: 7:30 – 9:30 a.m.
Location: Hilton Columbia
5485 Twin Knolls Road
Columbia, MD 21045 
Who: Employees of Biotech Companies* 
Fee: Free for GBTC members and $25 for non-members

Register here 

* A biotech company is defined as a company that generates or intends to generate at least 50% of its revenues from the development or sale of biotechnology products or biotechnology research.

In the current economic climate, all companies are looking for ways to alleviate risks and create competitive advantages. Some have found that strategic partnerships are the answer. Partnering is also becoming a significant source of funding for bioscience companies of all sizes. Strategic partnerships allow large companies to enhance their product portfolios and leverage technology breakthroughs, while smaller companies can benefit from an established company's experience in meeting FDA approval and organized sales policies to successfully handle product commercialization.

Panelists:
Kenneth C. Carter, Ph.D., President & CEO, Avalon Pharmaceuticals
Rob Gillison, Vice President of Corporate Development, Martek
Michael Tardugno, CEO, Celsion 

Supporting Organizations:
ETC: Emerging Technology Centers
MdBIO
Mtech
University of Maryland Baltimore
Women in Bio